However, among the bigger number of Beat-AML diagnosis samples for which the FAB is known (n = 275) and containing many samples in all FAB categories, a significantly higher expression of AKT3 in the M5 category appears, with a noticeable progressive increase in AKT3 expression from M1 to M5 groups. This evidence concerns the gene AKT3 and acute myeloid leukemia.